CAM
FLXN

Cortina Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Cortina Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-346,457
Closed -$4.32M – 192
2019
Q1 		$4.32M Buy
+346,457
New +$4.63M 0.27% 148

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Cortina Asset Management's FLXN Position: Q2 2019 in Review

Cortina Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 346,457 shares — an estimated $4.32M sold.

Cortina Asset Management first reported a position in FLXN in Q1 2019 and held it in 1 quarter. The position peaked at $4.32M in Q1 2019. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

  • Cortina Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Cortina Asset Management sold 346,457 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $4.32M.
  • Cortina Asset Management first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
  • Cortina Asset Management's Flexion Therapeutics, Inc. position peaked at $4.32M in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.